Vol 9, No 3 (2017)
Mol Cell Pharmacol
Table of Contents
Literature Highlights
| Alectinib (Alecensa) as First-line Option for ALK-positive Lung Cancer | Abstract PDF |
| M. Saeed Sheikh | 15 |
FDA Corner
| FDA Approval Brings First Gene Therapy to the United States | Abstract PDF |
| 17-18 |
| FDA Approves First Continuous Glucose Monitoring System for Adults Not Requiring Blood Sample Calibration | Abstract PDF |
| 18-19 |
| FDA Approves CAR-T Cell Therapy to Treat Adults With Certain Types of Large B-cell Lymphoma | Abstract PDF |
| 19-20 |
| FDA Approves First Once-Monthly Buprenorphine Injection, a Medication-assisted Treatment Option for Opioid Use Disorder | Abstract PDF |
| 20-21 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.